Volume 10, 2023

|
Editorials
HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!
https://doi.org/10.18632/oncoscience.572
Nidhi Garg, Mangesh A. Thorat
p 1-3
Editorials
New method of clustering colorectal cancer patients using differential presence of exons (DPE) sequencing
https://doi.org/10.18632/oncoscience.573
David Rubio-Mangas, Mariano García-Arranz, Javier Suela, Damian García-Olmo
p 4-5
Research Perspectives
Mitochondrial regulator ATAD3A: a molecular determinant favoring head and neck cancer development
https://doi.org/10.18632/oncoscience.574
Yong Teng
p 6-8
Editorials
UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?
https://doi.org/10.18632/oncoscience.575
Melisa Husein, Patrick Petignat, Marie Cohen
p 9-10
Research Perspectives
Think outside the box – atypical infections in chronic sinusitis
https://doi.org/10.18632/oncoscience.576
Florian Dudde, Kai-Olaf Henkel, Filip Barbarewicz
p 11-13
Research Perspectives
Cancer cell repopulation after therapy: which is the mechanism?
https://doi.org/10.18632/oncoscience.577
Rewati Prakash, Carlos M. Telleria
p 14-19
Editorials
Transforming early cancer detection in primary care: harnessing the power of machine learning
https://doi.org/10.18632/oncoscience.578
Elinor Nemlander, Marcela Ewing, Axel C. Carlsson, Andreas Rosenblad
p 20-21
Editorials
Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer
https://doi.org/10.18632/oncoscience.579
Deepak Bhamidipati, Vivek Subbiah
p 22-23
Editorials
Kinase-targeted therapy in subsets of colorectal cancer
https://doi.org/10.18632/oncoscience.580
Patricia M. Gomez Barila, Jan Paul Medema
p 24-26
Editorials
Adenoid cystic carcinoma of the head and neck – treatment strategies of a highly malignant tumor with variable localizations
https://doi.org/10.18632/oncoscience.581
Florian Dudde, Kai-Olaf Henkel, Filip Barbarewicz
p 27-29
Research Perspectives
Squamous cell carcinoma of the oral cavity – follow up treatment and distant metastatic behavior
https://doi.org/10.18632/oncoscience.582
Florian Dudde, Ina Giersdorf, Filip Barbarewicz, Kai-Olaf Henkel
p 30-31
Editorials
Cancer drug development yesterday, today and tomorrow
https://doi.org/10.18632/oncoscience.583
Elzbieta Izbicka, Robert T. Streeper
p 32-33
Editorials
Lipiodol: from intrusion until exile from the tumor microenvironment
https://doi.org/10.18632/oncoscience.584
Sheena Anand, Jean-François Geschwind, Vahid Etezadi, Nariman Nezami
p 34-35
Editorials
Exiting the pandemic together: achieving global immunity and equity
https://doi.org/10.18632/oncoscience.585
Yuxin Ying, Jola Bytyci, Lennard YW Lee
p 36-37
Case Reports
Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery
https://doi.org/10.18632/oncoscience.586
Mohamed A. Gouda, Filip Janku, Neeta Somaiah, Kelly K. Hunt, Sireesha Yedururi, Vivek Subbiah
p 38-43
Case Reports
Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma
https://doi.org/10.18632/oncoscience.587
Mohamed A. Gouda, Maria A. Zarzour, Ara A. Vaporciyan, Kalevi Kairemo, Hubert H. Chuang, Vivek Subbiah
p 44-53